Chemomab Therapeutics (CMMB) Institutional Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CMMB Stock Alerts $0.77 +0.02 (+2.67%) (As of 03/27/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$48,118.17Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$39,875.61 Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2023Two Sigma Investments LP30,263$48K0.0%N/A0.274% 5/15/2023Boothbay Fund Management LLC26,529$42K0.0%-48.6%0.240% 2/15/2023Boothbay Fund Management LLC51,608$0.17M0.0%+38.1%0.448% 2/1/2023Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 11/15/2022State Street Corp28,640$71K0.0%-20.9%0.251% 11/15/2022Citadel Advisors LLC21,226$53K0.0%N/A0.186% 5/13/2022Renaissance Technologies LLC27,960$0.13M0.0%N/A0.245% 5/4/2022Envestnet Asset Management Inc.10,807$52K0.0%N/A0.095% 2/14/2022GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022 ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021Advisor Group Holdings Inc.54,821$0.61M0.0%N/A0.481% 11/3/2021 Meitav Dash Investments Ltd.37,567$0.42M0.0%-7.6%0.330% 9/17/2021Virtu Financial LLC13,180$0.25M0.0%N/A0.116% 8/25/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$0.84M0.0%N/A0.386% 8/18/2021Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021 Meitav Dash Investments Ltd.40,664$0.77M0.0%+389.3%0.370% 8/17/2021Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021 Meitav Dash Investments Ltd.40,664$0.77M0.0%+389.3%0.380% 5/18/2021Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021Renaissance Technologies LLC7,023$0.20M0.0%N/A0.301% 5/6/2021 Meitav Dash Investments Ltd.8,311$0.24M0.0%N/A0.356% (Data available from 1/1/2016 forward) CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Renaissance Technologies LLC ($0.13M), Kestra Private Wealth Services LLC ($100K), State Street Corp ($71K), Citadel Advisors LLC ($53K), Envestnet Asset Management Inc. ($52K), and Two Sigma Investments LP ($48K), and Boothbay Fund Management LLC ($42K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Kestra Private Wealth Services LLC ($31.24K), Two Sigma Investments LP ($30.26K), Renaissance Technologies LLC ($27.96K), Citadel Advisors LLC ($21.23K), Boothbay Fund Management LLC ($14.24K), and Envestnet Asset Management Inc. ($10.81K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 135,734 shares in the last 24 months. This purchase volume represents approximately $0.43M in transactions. Which Chemomab Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Chemomab Therapeutics stock in the last 24 months: Boothbay Fund Management LLC ($25.08K), and State Street Corp ($7.55K). How much institutional selling is happening at Chemomab Therapeutics? Institutional investors have sold a total of 32,624 shares in the last 24 months. This volume of shares sold represents approximately $58.66K in transactions. Related Companies: VIRI Institutional Ownership CYCN Institutional Ownership ATHE Institutional Ownership TRVN Institutional Ownership BNOX Institutional Ownership CLVR Institutional Ownership LGVN Institutional Ownership PTIX Institutional Ownership CANF Institutional Ownership TNXP Institutional Ownership This page (NASDAQ:CMMB) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.